Home / Resources and Insights / Exploration of Nitromethane-Carbonylation Strategy

Exploration of Nitromethane-Carbonylation Strategy

Less than 1 min read time

Read this recently published Journal of Chemistry paper discussing how WuXi STA scientists and their partner AstraZeneca collaborated to improve...

Share this article:

Read this recently published Journal of Chemistry paper discussing how WuXi STA scientists and their partner AstraZeneca collaborated to improve the process for a synthetically challenging atropisomeric KRASG12C inhibitor, resulting in a reduced step count and streamlined protecting group strategy to support efficient clinical API manufacture.

View Article (PDF)

Skip to toolbar